42 results
Page 2 of 3
8-K
EX-99.1
t7olqtntz 2u
11 Jan 21
Regulation FD Disclosure
8:31am
8-K
EX-99.2
rqmalo
24 Sep 19
Durability of Response Determined to be 89 Percent at Six Months and 84 Percent at 12 Months
5:20pm
8-K
EX-99.3
kevfm
24 Sep 19
Durability of Response Determined to be 89 Percent at Six Months and 84 Percent at 12 Months
5:20pm
10-Q
pmjy9mzn4e6t gqw
9 May 19
Quarterly report
7:13am
10-K
clnbsgi028 67elmfh
28 Feb 19
Annual report
1:08pm
424B5
rns5cqs jfg
25 Jan 19
Prospectus supplement for primary offering
8:01am
424B5
q0kh3zmfx79vwts7
22 Jan 19
Prospectus supplement for primary offering
5:12pm
8-K
EX-99.2
va70x13c5s73zwy
22 Jan 19
UroGen Pharma Announces Proposed Public Offering of Ordinary Shares
5:08pm